Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
Cytosorbents (CTSO) - P/B ratio
P/B ratio as of April 2024 : 1.90
According to Cytosorbents's latest financial reports the company has a price-to-book ratio of 1.90.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Cytosorbents - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.49 | 30.13% |
| 2022-12-31 | 1.91 | -34.32% |
| 2021-12-31 | 2.91 | -33.06% |
| 2020-12-31 | 4.35 | -88.16% |
| 2019-12-31 | 36.7 | 142.33% |
| 2018-12-31 | 15.2 | -16.57% |
| 2017-12-31 | 18.2 | -82.49% |
| 2016-12-31 | 104 | 502.37% |
| 2015-12-31 | 17.2 | -70.55% |
| 2014-12-31 | 58.5 | -2756.89% |
| 2013-12-31 | -2.20 | -8.39% |
| 2012-12-31 | -2.40 | -14.54% |
| 2011-12-31 | -2.81 | -92.07% |
| 2010-12-31 | -35.5 | -456.75% |
| 2009-12-31 | 9.95 | 1061.36% |
| 2008-12-31 | 0.8566 | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 5.51 | 190.41% | 🇺🇸 USA |
 Hologic HOLX | 3.84 | 102.22% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 4.05 | 113.24% | 🇺🇸 USA |